Latest AI and machine learning research in oncology/hematology for healthcare professionals.
BACKGROUND: While artificial intelligence's (AI's) transformative potential in health care is widely...
BACKGROUND AND OBJECTIVE: Metastatic hormone-sensitive prostate cancer (mHSPC) exhibits heterogeneou...
OBJECTIVE: Lung adenocarcinoma (LUAD) molecular heterogeneity limits traditional prognostic models. ...
The surgical procedures for primary lung cancer and metastatic lung tumors differ. An intraoperative...
Malignant or high-grade vocal fold disease is usually judged across repeated laryngoscopic views at ...
RATIONALE AND OBJECTIVES: To evaluate the diagnostic performance of a longitudinal ultrasound (US)-b...
Metastatic renal cell carcinoma remains clinically challenging because of heterogeneous outcomes and...
Breast cancer is one of the most prevalent and lethal malignancies affecting women globally. The inc...
Given the rising incidence of bone metastases, computed tomography is widely used worldwide as the i...
BACKGROUND: Pancreatic cancer (PC) is a highly malignant tumor with increasing incidence, mortality,...
Despite rapid progress in multimodal spectroscopy for cancer diagnosis, its practical application re...
MRI and magnetic resonance cholangiopancreatography (MRCP) remain foundational techniques for the ev...
BACKGROUND AND OBJECTIVES: Combination therapy mitigates toxicity and resistance, yet experimental s...
BACKGROUND: Colorectal cancer (CRC) is one of the most common malignancies worldwide and remains a m...
OBJECTIVES: This study aims to evaluate provider-perceived accuracy, completeness, and clinical util...
BACKGROUND: Early detection of epithelial ovarian cancer (EOC) remains a major clinical challenge. A...
BACKGROUND: The functional roles of the S100 protein family in colorectal cancer (CRC) are enigmatic...
Artificial intelligence (AI) is reshaping every stage of leukemia diagnostics, from digital morpholo...
PURPOSE: The purpose of this study was to evaluate whether explicitly modeling diabetes mellitus (DM...
Tumor heterogeneity remains a major barrier to effective cancer therapy, driving the need for novel ...